English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/158149
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Leptolide improves insulin resistance in diet-induced obese mice

AuthorsVilla-Pérez, Pablo; Cueto, Mercedes ; Díaz-Marrero, Ana R. ; Lobatón, Carmen D.; Moreno, Alfredo; Perdomo, Germán; Cózar-Castellano, Irene
KeywordsHepG2 cells
Insulin resistance
Obesity
Type 2 diabetes
Leptolide
Issue Date2017
PublisherMolecular Diversity Preservation International
CitationMarine Drugs 15(9): 2889 (2017)
AbstractType 2 diabetes (T2DM) is a complex disease linked to pancreatic beta-cell failure and insulin resistance. Current antidiabetic treatment regimens for T2DM include insulin sensitizers and insulin secretagogues. We have previously demonstrated that leptolide, a member of the furanocembranolides family, promotes pancreatic beta-cell proliferation in mice. Considering the beneficial effects of leptolide in diabetic mice, in this study, we aimed to address the capability of leptolide to improve insulin resistance associated with the pathology of obesity. To this end, we tested the hypothesis that leptolide should protect against fatty acid-induced insulin resistance in hepatocytes. In a time-dependent manner, leptolide (0.1 µM) augmented insulin-stimulated phosphorylation of protein kinase B (PKB) by two-fold above vehicle-treated HepG2 cells. In addition, leptolide (0.1 µM) counteracted palmitate-induced insulin resistance by augmenting by four-fold insulin-stimulated phosphorylation of PKB in HepG2 cells. In vivo, acute intraperitoneal administration of leptolide (0.1 mg/kg and 1 mg/kg) improved glucose tolerance and insulin sensitivity in lean mice. Likewise, prolonged leptolide treatment (0.1 mg/kg) in diet-induced obese mice improved insulin sensitivity. These effects were paralleled with an ~50% increased of insulin-stimulated phosphorylation of PKB in liver and skeletal muscle and reduced circulating pro-inflammatory cytokines in obese mice. We concluded that leptolide significantly improves insulin sensitivity in vitro and in obese mice, suggesting that leptolide may be another potential treatment for T2DM
DescriptionThis article belongs to the Special Issue Marine Compounds and Inflammation II, 2017.
URIhttp://hdl.handle.net/10261/158149
DOI10.3390/md15090289
Identifiersdoi: 10.3390/md15090289
issn: 1660-3397
Appears in Collections:(IPNA) Artículos
(IBGM) Artículos
Files in This Item:
File Description SizeFormat 
InducedObeseMice.pdf2,38 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.